Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001013762-24-000517
Filing Date
2024-07-22
Accepted
2024-07-22 17:00:42
Documents
21

Document Format Files

Seq Description Document Type Size
1 REVISED PRELIMINARY PROXY STATEMENT ea0209797-prer14a_onconetix.htm PRER14A 4649940
2 GRAPHIC image_001.jpg GRAPHIC 25722
3 GRAPHIC image_002.jpg GRAPHIC 18527
4 GRAPHIC image_003.jpg GRAPHIC 14937
5 GRAPHIC image_004.jpg GRAPHIC 350000
6 GRAPHIC image_005.jpg GRAPHIC 324834
7 GRAPHIC image_006.jpg GRAPHIC 317830
8 GRAPHIC image_007.jpg GRAPHIC 84856
9 GRAPHIC image_008.jpg GRAPHIC 135404
10 GRAPHIC image_009.jpg GRAPHIC 172545
11 GRAPHIC image_010.jpg GRAPHIC 186878
12 GRAPHIC image_011.jpg GRAPHIC 847067
13 GRAPHIC image_012.jpg GRAPHIC 301266
14 GRAPHIC image_019.jpg GRAPHIC 83822
15 GRAPHIC image_013.jpg GRAPHIC 70985
16 GRAPHIC image_014.jpg GRAPHIC 139284
17 GRAPHIC image_015.jpg GRAPHIC 177373
18 GRAPHIC image_016.jpg GRAPHIC 619875
19 GRAPHIC image_017.jpg GRAPHIC 707914
20 GRAPHIC image_018.jpg GRAPHIC 65496
21 GRAPHIC annexc_001.jpg GRAPHIC 2958
  Complete submission text file 0001013762-24-000517.txt   11052269
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-41294 | Film No.: 241132149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)